Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma

Published:2017-07-29 Issue:11 Volume:143 Page:2351-2361
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Hatogai Ken,Fujii Satoshi,Kojima Takashi,Daiko Hiroyuki,Nomura Shogo,Doi Toshihiko,Kitano Shigehisa,Ohtsu Atsushi,Takiguchi Yuichi,Yoshino Takayuki,Ochiai Atsushi

Funder

Health and Labor Science Research Grant

National Cancer Center Hopital East funding

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-017-2482-7/fulltext.html

Reference32 articles.

1. Abedi-Ardekani B, Dar NA, Mir MM, Zargar SA, Lone MM, Martel-Planche G, Villar S, Mounawar M, Saidi F, Malekzadeh R et al (2012) Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia. BMC Cancer 12:602

2. Chen K, Cheng G, Zhang F, Zhang N, Li D, Jin J, Wu J, Ying L, Mao W, Su D (2016) Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma. Oncotarget 7:30772–30780

3. Comoglio PM, Giordano S, Trusolino L (2008) Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7:504–516

4. Crosby T, Hurt CN, Falk S, Gollins S, Mukherjee S, Staffurth J, Ray R, Bashir N, Bridgewater JA, Geh JI et al (2013) Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. Lancet Oncol 14:627–637

5. Doi T, Piha-Paul SA, Jalal SI, Mai-Dang H, Yuan S, Koshiji M, Csiki I, Bennouna J (2015) Pembrolizumab (MK-3475) for patients (pts) with advanced esophageal carcinoma: preliminary results from KEYNOTE-028. In: ASCO annual meeting, p. Abstract 4010, Chicago

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment;Scientific Reports;2022-11-23

2. Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis;Molecular Diagnosis & Therapy;2022-02-01

3. Biomarkers in Gastrointestinal System Carcinomas;Biomarkers in Carcinoma of Unknown Primary;2022

4. Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo;Annals of Translational Medicine;2021-12

5. Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451;Journal of Clinical Oncology;2021-04-20